Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase I Clinical Trial of GPC2 Chimeric Antigen Receptor T (GPC2-CAR T) Cells for Relapsed or Refractory Medulloblastoma in Children and Young Adults

This is a single-site, open-label Phase 1 clinical trial evaluating the feasibility, safety, and preliminary activity of autologous GPC2-targeted chimeric anti…

MedulloblastomaCentral Nervous System Embryonal TumorRefractory Medulloblastoma+7 more

Stanford UniversityNCT07087002